Table 1.
Characteristics of subjects
| Patients (21) | Controls(21) | P value | |
|---|---|---|---|
| Age (yrs) | 71 ± 6 | 70 ± 6 | – |
| Post-menopausalperiod (yrs) | 22 ± 9 | 21 ± 7 | NS |
| DMduration (yrs) | 16 ± 2 | – | – |
| HbA1C (mmol/mol) | 57 ± 8.1 | – | – |
| DM complications (%) | 42.9% | – | – |
| Retinopathy (%) | 14.3% | – | – |
| Neuropathy + retinopathy (%) | 4.8% | – | – |
| Neuropathy (%) | 23.8% | – | – |
| Insulin treatment (%) | 23.8% | ||
| Metformin treatment (%) | 52.4% | ||
| DPP4 inhibitors treatment (%) | 23.8% | ||
| Waist/hip ratio | 0.92 (0.88–0.96) | 0.88 (0.84–0.94) | NS |
| Fat mass (%) | 39.4 (36.1–41.1) | 39.1 (34.1–42.3) | NS |
| BMI (Kg/m2) | 29 ± 5 | 29 ± 5 | – |
Data depicted are mean ± SD for Gaussian variables and median with 25° and 75° percentiles for non-Gaussian variables, non-continuous variables are shown percentage. Statistical differences were analyzed by using ANOVA one-way or Mann-Whitney U test